Celldex News, Celldex Quote, CLDX Quote

Celldex (NQ:CLDX) Delayed: 27.53 -1.4 (4.84%)

Prev. Close

$28.93

Today 6M 1Y 5Y

Open

$28.89

52 Wk High

$18.62

52 Wk Low

$2.85

Day High

$28.89

Day Low

$27.47

P/E

N/A

EPS

$-1.02

Volume

997,973

Friends, Peers and Foes (?): NBI, ORKA, ALK, OKLO, PEGA (more...)

ALERTS | RSS

Oct 7, 2026 11:47 AM Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: FMR LLC
Sep 27, 2026 04:00 AM Guggenheim says investors should own this biotech stock
Sep 23, 2026 06:19 AM Celldex Therapeutics (CLDX) PT Raised to $57 at Morgan Stanley
Sep 22, 2026 10:21 AM Stifel Reiterates Buy Rating on Celldex Therapeutics (CLDX)
Sep 22, 2026 07:09 AM Form 8-K Celldex Therapeutics, For: Sep 22
Sep 22, 2026 06:58 AM Celldex's barzolvolimab meets Phase 3 endpoints in chronic hives trial
Sep 22, 2026 06:58 AM Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints
Sep 10, 2026 07:59 AM Celldex Therapeutics (CLDX) PT Raised to $50 at Morgan Stanley
Sep 8, 2026 04:01 PM Celldex to Present at Upcoming Investor Conference
Aug 14, 2026 12:09 PM Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: Kynam Capital Management, LP

Entities mentioned with CLDX

View All Entities